Top Healthcare Stocks: Playing Offense And Defense For The Win

Impact · against what's priced in

The article provides no material catalyst for BTSG as its general positive outlook is already baked into the current valuation. AVAH and NUTX receive a positive but modest signal due to their inclusion in a high-growth healthcare quant screen.

BTSG+0.00

Already priced in

The price assumes

The current 14.6% revenue growth

The author's claim that healthcare services are positioned for above-average long-term growth simply reinforces the revenue growth the market already assumes in the current price.